Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan

RMD Open. 2023 Aug;9(3):e003435. doi: 10.1136/rmdopen-2023-003435.
No abstract available

Keywords: COVID-19; Systemic vasculitis; Vaccination.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds
  • COVID-19*
  • Humans
  • Nipecotic Acids

Substances

  • avacopan
  • Aniline Compounds
  • Nipecotic Acids